Skip to content

Controling of pain and stress associated with peripheral venous thrombosis in children

Comparison of three methods of verbal speaking intranasal injection of midazolam and ketamine intranasal injection in control of pain and stress associated with peripheral venous thrombosis in children

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151003024317N8
Enrollment
100
Registered
2019-09-28
Start date
2019-10-02
Completion date
Unknown
Last updated
2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral vein in children.

Interventions

Intervention 1: Intervention group: Intranasal injection of Midazolam 0.2 mg / kg, 20 minutes before the procedure with the MAD. Intervention 2: Intervention group: Intranasal injection of Ketamine 5

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 10 Years

Inclusion criteria

Inclusion criteria: Age over one year Parental consent for the child to participate in the project

Exclusion criteria

Exclusion criteria: Immunodeficiency Down syndrome Chronic heart and pulmonary disease

Design outcomes

Primary

MeasureTime frame
Saturation of oxygen. Timepoint: 10 minutes after the procedure. Method of measurement: Pulse Oximetry.;The number of pulses. Timepoint: 10 minutes after the procedure. Method of measurement: Based on patient records.;Breath rate. Timepoint: 10 minutes after the procedure. Method of measurement: Based on patient records.;The severity of pain after the procedure. Timepoint: 10 minutes after the procedure. Method of measurement: Observational Scale of Behavioral Distress-Revised.;The amount of sedation. Timepoint: 10 minutes after the procedure. Method of measurement: Observational Scale of Behavioral Distress-Revised.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShabahang Jafarnejad

Iran University of Medical Sciences

shabahangjafarnejad@yahoo.com+98 21 86701

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026